Can metformin stabilize PCSK9 level in stable coronary artery disease patients treated with statins?

The addition of metformin to ongoing rosuvastatin therapy did not significantly affect serum lipid levels, but stabilized the level of circulating PCSK9, compared with the group without metformin treatment.